A Study of Samuraciclib in Combination With Fulvestrant in Metastatic or Locally Advanced Breast Cancer in Adult Participants
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Metastatic Breast Cancer|Locally Advanced Breast Cancer|Breast Cancer
Interventions: DRUG: Samuraciclib|DRUG: Fulvestrant
Sponsor: Carrick Therapeutics Limited
Collaborators: Pfizer